Features of human papillomavirus infection and cervical cancer prevalence in pre-vaccination and early vaccination periods in the Republic Sakha (Yakutia)
Abstract
The research aims at studying patterns and regional characteristics of morbidity and incidence of various papillomavirus infection and cervical cancer forms in the Republic of Sakha (Yakutia) in the pre-vaccination period and the first years of vaccination against this pathology. It is established that the studied periods do not show any significant differences or decreasing trend in anogenital (venereal) warts morbidity. The study revealed higher (by 1/6-2 times) incidence of high-risk HPV of type 16 in women, compared with men. There was no decrease in type 16 and 18 HPV incidence in 2008-2011 (the period of introducing low vaccination coverage), compared with the year 2007. There is a trend for increased CC morbidity in women aged 30-44 years.
About the Authors
M. E. Ignatieva
УФС по надзору в сфере защиты прав потребителей по РС(Я)
Russian Federation
Russian Federation
L. V. Lyalina
НИИ эпидемиологии и микробиологии им. Пастера
Russian Federation
Russian Federation
V. D. Smetanina
ГБУ РС(Я) «Якутский республиканский онкологический диспансер»
Russian Federation
Russian Federation
I. I. Karpova
ГБУ РС(Я) «Якутский республиканский кожно-венерологический диспансер»
Russian Federation
Russian Federation
L. N. Afanasyeva
ЯНЦ КМП СО РАМН, ИПОВ СВФУ им. М.К. Аммосова;
Управление здравоохранения г. Якутска при МЗ РС(Я)
Russian Federation
Russian Federation
References
1. Vaccines for the Prevention of Cervical Cancer / Ed. P.L. Stern, G.S. Kitchener; translated from English; under general edition of Academic G.T. Sukhih, Prof. V.N. Prilepskya. – Moscow.: MEDpress-inform, 2009. – 192 pp.
2. Medical and Social Aspects of Prevention of Pappilomavirus Infection and Related Malignant Growths / L.V. Lyalina, A.A. Lyshev, Yu.N. Filippova [et al.] // Epidemiology and Vaccination. – 2005. - #3(22). – pp. 31-34.
3. Shipulina O.Yu. First results of the preclinical research of school girls to detect high-risk human papillomavirus DNA / O.Yu. Shipulina, I.V. Mikheeva, D.A. Kuevda // Proceedings of the International Symposium ‘Papillomavirus Infection and Malignant Growths. Integrated Monitoring and Prevention System’. St. Petersburg, June 4- 5-, 2009. – SPb, 2009. – pp. 44-46.
4. Epidemiological aspects of pappilomavirus infection in reproductive-age women in Tomsk region / L.N. Urazova, E.G. Nikitina, M.K. Merzlyakova et al. // Proceedings of the II International Symposium ‘Papillomavirus Infection and Malignant Growths. Integrated Monitoring and Prevention System’. St. Petersburg, June 7- 9-, 2011. – SPb, 2011. – pp. 14-23.
5. Cancer Research for Cancer Control // International Agency for Research on Cancer WHO. – Lyon, 2001. – 35 p.
6. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data / B. Donovan, N. Franklin, R. Guy [et al.] // Lancet Infect. Dis. – 2011. – Vol.11. – P.39-44.
7. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomized, double-blind trial / N. Munoz, R. Manalastas Jr, P. Pitisuttithum [et al.] // Lancet. – 2009. – Vol. 373. – P.1949-1957.
8. Stanley M. A Practitioners Guide to Understanding Immunity to Human Papillomavirus / M. Stanley // US Obstetrics & Gynecology. – 2009. – Vol. 4 (1). – P.10-15.
9. The causal relation between human papillomavirus and cervical cancer / F.X. Bosch, A. Lorincz, N. Munoz [et al.] // J. Clin. Pathology. – 2002. – Vol. 55. – P.244-265.
10. Zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancer / H. Zur Hausen // Cancer Res. – 1989. – Vol. 49. – P.4677-4681.
Review
For citations:
Ignatieva M.E., Lyalina L.V., Smetanina V.D., Karpova I.I., Afanasyeva L.N. Features of human papillomavirus infection and cervical cancer prevalence in pre-vaccination and early vaccination periods in the Republic Sakha (Yakutia). Yakut Medical Journal. 2012;(3):63-65.
Views:
27
Email this article 